When repeated biopsy dramatically changes treatment tactics in metastatic castration-refractory prostate cancer with neuroendocrine transformation: clinical case and literature review-Reference-Cited by-同舟云学术

When repeated biopsy dramatically changes treatment tactics in metastatic castration-refractory prostate cancer with neuroendocrine transformation: clinical case and literature review

Published:2024-08-15 Issue:2 Volume:20 Page:122-128
ISSN:1996-1812
Container-title:Cancer Urology
language:
Short-container-title:Onkourologiâ

Author:

Usoltseva I. S.¹^ORCID,Parsadanova E. L.¹^ORCID,Kim Yu. K.²

Affiliation:

1. Sakhalin Regional Clinical Oncological Dispensary

2. Sakhalin Regional Pathologoanatomical Bureau

Abstract

Neuroendocrine neoplasia of the prostate gland is a rather rare neuroendocrine carcinoma characterized by poor prognosis. With an atypical course of prostate adenocarcinoma in certain cases, it is possible to suspect development of secondary neuroendocrine cancer. A timely repeat biopsy and correct diagnosis can affect both the patient’s life expectancy and his quality of life.

Publisher

Publishing House ABV Press

Reference22 articles.

1. Abbas F., Civantos F., Benedetto P., Soloway M.S. Small cell carcinoma of the bladder and prostate. Urology 1995;46(5):617–30. DOI: 10.1016/S0090-4295(99)80290-8

2. Cohen R.J., Glezerson G., Taylor L.F. et al. The neuroendocrine cell population of the human prostate gland. J Urol 1993;150(2 Pt 1): 365–8. DOI: 10.1016/s0022-5347(17)35484-8

3. Abbasova D.V., Polikarpova S.B., Kozlov N.A. et al. Neuroendocrine carcinoma of the prostate (review of the literature). Sovremennaya onkologiya = Journal of Modern Oncology 2019;21(3):52–5. (In Russ.). DOI: 10.26442/18151434.2019.3.190673

4. Frank G.A., Andreeva Yu.Yu., Moskvina L.V. et al. A new WHO classification of prostate tumors. Arkhiv patologii = Russian Journal of Archive of Pathology 2016;78(4):32–42. (In Russ.) DOI: 10.17116/patol201678432-42

5. Treatment and survival of patients with cancer of the prostate. The Veterans Administration Co-operative Urological Research Group. Surg Gynecol Obstet 1967;124(5):1011–7.